Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Sykehuset Innlandet HF.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Sykehuset Innlandet HF
Information provided by:
Sykehuset Innlandet HF
ClinicalTrials.gov Identifier:
NCT01318174
First received: March 17, 2011
Last updated: April 14, 2011
Last verified: February 2011
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | March 17, 2011 | ||||
| Last Updated Date | April 14, 2011 | ||||
| Start Date ICMJE | April 2011 | ||||
| Estimated Primary Completion Date | April 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | Complete list of historical versions of study NCT01318174 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease | ||||
| Official Title ICMJE | Prevalence of Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease | ||||
| Brief Summary | The purpose of this study is to determine the prevalence of pulmonary embolism in our population of Chronic Obstructive Pulmonary Disease (COPD) patients admitted to hospital with dyspnea. The patients will undergo investigation for pulmonary embolism, according to current guidelines. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Patients with known or suspected COPD admitted with an exacerbation of unknown aetiology |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 100 | ||||
| Estimated Completion Date | April 2012 | ||||
| Estimated Primary Completion Date | April 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Norway | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01318174 | ||||
| Other Study ID Numbers ICMJE | LE-KE | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Aleksander Talgøy Holten, PhD, MD, Sykehuset Innlandet HF | ||||
| Study Sponsor ICMJE | Sykehuset Innlandet HF | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Sykehuset Innlandet HF | ||||
| Verification Date | February 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||